Tamarindus Indica Seed Polysaccharide (Tsp)
Recommended · restricted OphthalmologyAuthority RequiredNot applicable line
Treatment of severe dry eye syndrome, including Sjogren's syndrome, in patients who are sensitive to preservatives in multi-dose eye drops.
1
Submissions
2007–07
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Jul 2007Recommended · restricted
vs carmellose sodium eye drops (Cellufresh)
- PBS listing · Authority Required
RecommendedDeferredNot recommended
From the public summary
Economic analysis
11. Estimated PBS Usage and Financial Implications The number of scripts dispensed was estimated by the submission to be in the range 10,000 – 50,000 in year 4 of listing.PSD · Jul 2007
The cost to the PBS was estimated by the submission to be < $10 million in year 4 of listing.PSD · Jul 2007
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated as no efficacy superiority was claimed.
The submission stated that as no efficacy superiority is claimed for TSP daily dose units, no economic evaluation had been undertaken. PSD · 2007
Decision context
PopulationPatients with severe dry eye syndrome, including Sjogren's syndrome, who are sensitive to preservatives in multi-dose eye drops.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Jul 2007 | Recommended · restricted | carmellose sodium eye drops (Cellufresh) | — | Registry |